Quarterly Results

  • Company Name :
Parmax Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 540359
  • NSE Symbol:
  • -
  • P/E(TTM):
  • 0.00
  • ISIN Demat:
  • INE240T01014
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 0.00
  • Book Value(₹):
  • -14.81
  • Market Cap(₹Cr.):
  • 13.28
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 2.53 1.94 4.83
Excise Duty 0.00 0.00 0.00
Net Sales 2.53 1.94 4.83
Other Operating Income 0.00 0.00 0.00
Other Income 0.01 0.01 -0.10
Total Income 2.54 1.95 4.73
Total Expenditure 4.12 2.19 6.46
PBIDT -1.58 -0.24 -1.74
Interest 0.24 0.28 0.24
PBDT -1.82 -0.52 -1.97
Depreciation 0.26 0.24 -0.18
Tax 0.00 0.00 0.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -0.30
Reported Profit After Tax -2.08 -0.76 -1.49
Extra-ordinary Items 0.00 0.00 -1.07
Adjusted Profit After Extra-ordinary item -2.08 -0.76 -0.42
EPS (Unit Curr.) -5.56 -2.04 -4.00
EPS (Adj) (Unit Curr.) -5.56 -2.04 -4.00
Calculated EPS (Unit Curr.) -5.56 -2.04 -4.00
Calculated EPS (Adj) (Unit Curr.) -5.56 -2.04 -4.00
Calculated EPS (Ann.) (Unit Curr.) -22.22 -8.17 -15.98
Calculated EPS (Adj) (Ann.) (Unit Curr.) -22.22 -8.17 -15.98
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 3.74 3.74 3.74
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) -62.45 -12.37 -36.02
PBDTM(%) -71.94 -26.80 -40.79
PATM(%) -82.21 -39.18 -30.85